FT819 in Subjects With B-cell Malignancies

Clinical trial NCT04629729 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04629729
Sponsor: Fate Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, B-Cell Chronic Lymphocytic Leukemia Precursor B-Cell Acute Lymphoblastic Leukemia

Start date: 2021-07-12
Primary completion: 2025-06-18
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.